Nitric oxide alters the expression of gamma-globin, H-ferritin, and transferrin receptor in human K562 cells at the posttranscriptional level

Autor: Jb, Domachowske, Sp, Rafferty, Singhania N, Rd, Mardiney M., Harry Malech

Publikováno v: Europe PubMed Central

Cellular iron metabolism is altered during chronic inflammatory states, leading to reticuloendothelial iron sequestration and an associated anemia. To study the effects of nitric oxide (NO) on the expression of three genes involved in erythroid cell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f62ae55dc84b13b9a7ce168a2aaa9769
http://europepmc.org/abstract/med/8874195

Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY).

Autor: Tuffy KM; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. Electronic address: Kevin.Tuffy@astrazeneca.com., Ahani B; Bioinformatics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Domachowske JB; Department of Pediatrics, SUNY Upstate Medical University, Syracuse, NY, USA., Furuno K; Department of General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan., Ji H; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Mankad VS; Clinical Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA., Hamrén UW; Clinical Pharmacology and Quantitative Pharmacology, R&D, AstraZeneca, Gothenburg, Sweden., Villafana T; Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Wang Y; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Kelly EJ; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Wilkins D; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.

Publikováno v: Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126276. Date of Electronic Publication: 2024 Sep 05.

Introduction to This JPIDS Supplement: All Infant Protection Against Serious RSV Disease.

Autor: Domachowske JB; SUNY Upstate Medical University, Pediatrics, New York City, New York, USA.

Publikováno v: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2024 Jul 12; Vol. 13 (Supplement_2), pp. S91-S92.

Population Attributable Risk of Wheeze in 2-<6-Year-old Children, Following a Respiratory Syncytial Virus Lower Respiratory Tract Infection in The First 2 Years of Life.

Autor: Madhi SA; From the South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Ceballos A; Instituto Medico Rio Cuarto, Rio Cuarto, Còrdoba, Argentina., Cousin L; Centro de Investigacion DEMEDICA, San Pedro Sula, Honduras., Domachowske JB; Department of Pediatrics, State University of New York Upstate Medical University, Syracuse, New York., Langley JM; Canadian Center for Vaccinology, IWK Health and Nova Scotia Health, Dalhousie University, Halifax, Nova Scotia, Canada., Lu E; GSK, Rockville, Maryland., Puthanakit T; Division of Infectious Diseases, Department of Pediatrics, Center of Excellence for Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Rämet M; Faculty of Medicine and Health Technology, Tampere University, and FVR - Finnish Vaccine Research, Tampere, Finland., Tan A; GSK, Rockville, Maryland., Zaman K; Division of Infectious Diseases, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Anspach B; GSK, Rockville, Maryland., Bueso A; Centro de Investigacion DEMEDICA, San Pedro Sula, Honduras., Cinconze E; GSK, Siena, Italy., Colas JA; Keyrus Life Sciences (c/o GSK), New York, New York., D'Andrea U; Instituto Medico Rio Cuarto, Rio Cuarto, Còrdoba, Argentina., Dieussaert I; GSK, Wavre, Belgium., Englund JA; Division of Pediatric Infectious Diseases, Department of Pediatrics, Seattle Children's Research Institute, University of Washington, Seattle, Washington., Gandhi S; GSK India Global Services Private Limited, Mumbai, India., Jose L; From the South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Karhusaari H; Faculty of Medicine and Health Technology, Tampere University, and FVR - Finnish Vaccine Research, Tampere, Finland., Kim JH; GSK, Rockville, Maryland., Klein NP; Kaiser Permanente Vaccine Study Center, Division of Research, Kaiser Permanente Northern California, Oakland, California., Laajalahti O; Faculty of Medicine and Health Technology, Tampere University, and FVR - Finnish Vaccine Research, Tampere, Finland., Mithani R; GSK, Rockville, Maryland., Ota MOC; GSK, Wavre, Belgium., Pinto M; Centro de Investigacion DEMEDICA, San Pedro Sula, Honduras., Silas P; Wee Care Pediatrics Syracuse, Syracuse, Utah., Stoszek SK; GSK, Rockville, Maryland., Tangsathapornpong A; Division of Pediatric Infectious Disease, Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand., Teeratakulpisarn J; Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Virta M; Faculty of Medicine and Health Technology, Tampere University, and FVR - Finnish Vaccine Research, Tampere, Finland., Cohen RA; GSK, Rockville, Maryland.

Publikováno v: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2024 Jul 01. Date of Electronic Publication: 2024 Jul 01.

Vaccine knowledge, attitudes, and recommendation practices among health care providers in New York State.

Autor: Fernandes A; Pediatrics, SUNY Upstate Medical University, Syracuse, NY, USA., Wang D; Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY, USA., Domachowske JB; Pediatrics, SUNY Upstate Medical University, Syracuse, NY, USA., Suryadevara M; Pediatrics, SUNY Upstate Medical University, Syracuse, NY, USA.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2173914. Date of Electronic Publication: 2023 Feb 07.